Journal of Vaccines and Immunology Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesYes
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editorial Board

    David Allen Reardon
    Professor
    Neuro Oncology
    Harvard Cancer Center
    USA
    JVI

    David A. Reardon, MD, is a Professor of Medicine at Harvard Medical School and currently serves as Clinical Director of the Center for Neuro-Oncology at the Dana-Farber Cancer Institute.

     

    He previously served as the Associate Deputy Director of the Preston Robert Tisch Brain Tumor Center at Duke University Medical Center for eleven years. He completed his residency at John Hopkins Hospital in Maryland, USA and was awarded a fellowship at the University of Michigan. Dr. Reardon is an active researcher with special interests in the design and implementation of clinical trials for neuro-oncology and the preclinical evaluation of promising therapeutics for central nervous system tumors.

     

    His work includes using innovative clinical therapeutic agents to improve outcome for patients with brain and spinal tumors, with particular focus on immunotherapeutics. He has also led investigations of molecular-targeting agents, anti-angiogenic reagents, cytotoxins and other biologically-based therapies.

     

    Dr. Reardon has published over 290 peer-reviewed manuscripts. He received the R. Wayne Rundles Award for Excellence in Cancer Research as well as the Award for Excellence in Adult Clinical Research by the Society for Neuro-Oncology in 2015 and 2016. He also served as the tenth president of the Society for Neuro-Oncology from 2013-2015.

    Research Interest: Innovative Clinical Therapeutic Agents To Improve Cure Rates In Patients With Brain And Spinal Tumors, With Particular Focus On Immunotherapeutics As Well As Molecular-Targeting Agents, Anti-Angiogenic Reagents, Cytotoxins And Other Biologically-Based Therapies.

    More Info.
    Min Wan
    Assistant Professor
    Karolinska Institutet
    Sweden
    JVI

    Research Interest: Inflammation, Immunology, Innate immunity, Infection, Antimicrobial peptides
    Lipid mediators.

    More Info.
    Yu-Chen Hu
    Department of Chemical Engineering
    National Tsing Hua University
    Taiwan
    JVI

    Research Interest: Gene therapy, Cell and tissue engineering, Vaccine development, Biomaterials, Synthetic biology and biomass, Nanobiotechnology.

    More Info.
    Pele Choi-Sing Chong
    Founder of Vaccine Research and Development Center
    National Institute of Infectious Diseases and Vaccinology
    Taiwan
    JVI

    Research Interest: Protein Engineering, Adjuvant and Vaccine Delivery Systems, Vaccinology, cGMP Quality Management, Immunology.

    More Info.
    Andrea Poscia
    Public Health Institute
    Catholic University of Sacred Heart of Rome
    Italy
    JVI

    Research Interest: HTA and to new communication strategies with people about vaccination, especially in consideration of the rising phenomena of anti-vaccination movements.

    More Info.
    Weida Liu
    Professor
    Head, Department of Medical Mycology
    Chinese Academy of Medical Sciences
    China
    JVI

    Research Interest: Diagnosis of fungal infections; Therapy of mycoses; Pathogenesis of fungal infection; Antifungal drug resistance; Fungal infection animal model; Genomics in medical mycology; Candida mucosal immunity; Infectious dermatosis; genodermatoses.

    More Info.
    Salvatore Chirumbolo
    Professor
    Department of Pathology and Diagnostics
    University of Verona
    Italy
    JVI

    Research Interest: Allergy test in clinical diagnosis, Immunotherapy and in vitro cell assay, Anti-inflammatory properties of natural compounds, Allergy and vaccination, Basophil activation tests.

    More Info.
    Mishra Kamla Prasad
    Department of Allied Sciences
    Defence Institute of Physiology
    India
    JVI

    Research Interest: Develop treatment modality/Process/Biomarkers for the soldiers working in the extreme conditions. Based on these stressors, different models of stress like hypobaric hypoxia, cold, Isolation (Antarctica) and viral infection are being used to overcome from the stress induced maladies.

    More Info.
    Prathap Pillai
    Department of Respiratory Medicine/Allergy
    Public university in London
    UK
    JVI

    Research Interest: Pre-treatment staging of lung cancer using integrated CT-PET and comparing its accuracy with conventional CT scan and pathological staging. Prospective study on the incidence of post-needle biopsy pneumothorax looking  at the relationship between early lung function testing  manoeuvre, after full radiological expansion of lung and recurrence of pneumothorax. UP-FRONT FDG CT-PET study - Prospective study to look at whether performing Up-Front FDG CT-PET in the pre-treatment evaluation of lung cancer reduces time interval and the number of invasive procedures for definitive diagnosis.

    More Info.
    Kuo C SHENG
    Research Fellow
    Griffith University
    Australia
    JVI

    Research Interest: Cancer immunology, vaccines, cancer, antigen-presenting cells and viral immunology.

    More Info.
    Suh-Chin Wu
    Professor
    Institute of Biotechnology
    National Tsing Hua University
    Taiwan
    JVI

    Research Interest: Biotechnology, Vaccines, Vaccine Development, Virology, Viral Vaccines.

    More Info.
    Changyu Zheng
    Staff Scientist National Institutes of Health
    USA
    JVI

    Research Interest: Basic Biology/Physiology Of Salivary Glands, Prevention Of Radiation-Induced Salivary Gland Damage, Gene Transfer To Salivary Glands, Viral Vector Modification And Improving Viral Vectors For Gene Transfer.

    More Info.
    Krzysztof Jerzy Rypula
    Division of Infectious Diseases and Veterinary Administration
    Wroclaw University
    Poland
    JVI

    Research Interest: Infectious diseases in animals, diagnostics, epidemiology, efficiency of vaccination programmes.

    More Info.
    Jianjun Zhao
    Institute of Special Economic Animal and Plant Sciences
    Sichuan Agriculture University
    China
    JVI

    Research Interest: Veterinary Vaccine and Immunology, Veterinay Virology (Canine distemper virus, Canine parvovorus and Classical swine fever virus.

    More Info.
    Fan Pan
    Professor of Oncology
    Department of Immunology and Hematopoiesis
    Johns Hopkins University
    USA
    JVI

    Research Interest: Oncology, Immunology and Hematopoiesis.

    More Info.
    View more
    mendeley

    Lessons from COVID-19: Overcoming Vaccine Hesitancy for the Malaria Vaccine in Africa

    DOI Logo 10.17352/jvi.000061

    Published On: June 13, 2025 | Pages: 001 - 003

    Author(s): Audry Marorerwa*, Guy Tresor Karikera and Egide Haragirimana
    Abstract View Full Article View
    mendeley

    Post-vaccinal reactions following vaccination with the COVID-19 vaccine after first and second dose

    DOI Logo 10.17352/jvi.000060

    Published On: March 05, 2024 | Pages: 006 - 010

    Author(s): Velina Stoeva*, Rosen Mihaylov, Blagovesta Pencheva and Antoineta Mihova

    ORCID Logo  0000-0002-6239-4418

    Abstract View Full Article View
    mendeley

    Considerations for improving future pandemic responses

    DOI Logo 10.17352/jvi.000059

    Published On: February 08, 2024 | Pages: 001 - 005

    Author(s): Mikolaj Raszek*, David Cowley and Alberto Rubio-Casillas

    ORCID Logo  0009-0003-5755-3415

    Abstract View Full Article View
    mendeley

    Evaluation of Anti-SARS-CoV-2 IgG antibody response following COVISHEILD vaccination: A comparison between previously infected and non-infected cohorts

    DOI Logo 10.17352/jvi.000058

    Published On: August 19, 2023 | Pages: 030 - 036

    Author(s): Md Shakeel Ahmed*, Md Zakir Hossain, Md Mamunur Rashid, Istiak Ahmad, Md Zahirul Islam, Meherab Hossain and Hasan Rabbi

    ORCID Logo  0000-0002-3405-2146

    Abstract View Full Article View
    mendeley

    Dietary intervention in enhancing immunity of cancer patients

    DOI Logo 10.17352/jvi.000057

    Published On: August 09, 2023 | Pages: 024 - 029

    Author(s): Dietary intervention in enhancing immunity of cancer patients

    ORCID Logo  0000-0001-8856-3681

    Abstract View Full Article View
    mendeley

    Percutaneous Patent Ductus Arteriosus (PDA) closure: When and how to close Coil VS Occluder “step by step” cases report

    DOI Logo 10.17352/jvi.000056

    Published On: March 22, 2023 | Pages: 015 - 023

    Author(s): Nassime Zaoui*, Amina Boukabous, Nabil Irid, Katia Babou and Sabrina Benamara
    Abstract View Full Article View
    mendeley

    Study of adverse events following 2018 sub-national yellow fever vaccination in Ghana

    DOI Logo 10.17352/jvi.000055

    Published On: February 25, 2023 | Pages: 006 - 014

    Author(s): Douglas Adu-Fokuo, Feng Cheng*, Emily Yin and Elizabeth Giwa
    Abstract View Full Article View
    mendeley

    Alopecia areata

    DOI Logo 10.17352/jvi.000054

    Published On: February 21, 2023 | Pages: 001 - 005

    Author(s): Chieh Chen*

    ORCID Logo  0000-0001-5784-9855

    Abstract View Full Article View
    mendeley

    Characterization of enterotoxigenic Escherichia coli heat-labile toxin (LT) double mutant LTA72R/R192G as a Nontoxic and Effective Mucosal Adjuvant

    DOI Logo 10.17352/jvi.000053

    Published On: October 26, 2022 | Pages: 033 - 039

    Author(s): Li Ben-Qiang, Tao Jie, Cheng Jing-Hua, Shi Ying and Liu Hui-li*
    Abstract View Full Article View
    mendeley

    Effect of a third booster dose of COVID-19 mRNA vaccine in patients with haematological cancer after the initial two-dose vaccination - a single centre report

    DOI Logo 10.17352/jvi.000052

    Published On: August 08, 2022 | Pages: 029 - 032

    Author(s): Šušol Ondrej, Šušolová Barbora and Hájek Roman*
    Abstract View Full Article View

     

    Indexing/Archiving